79
Views
22
CrossRef citations to date
0
Altmetric
Case Report

Combined Initial Cyclophosphamide with Repeated Methylprednisolone Pulse Therapy for Severe Paraquat Poisoning from Dermal Exposure

, M.D., , M.D., & , M.D.
Pages 877-881 | Published online: 30 Oct 2003

References

  • Vale J. A., Meredith T. J., Buckley B. M. Paraquat poisoning: clinical features and immediate general management. Hum Toxicol 1987; 6(1)41–47
  • Lin J. L. Acute paraquat poisoning. Clin Med (Taiwan) 1990; 26(6)352–358
  • Proudfoot A. T., Stewart M. S., Levitt T., Widdop B. Paraquat poisoning: significance of plasma paraquat concentration. Lancet 1979; 2(8138)330–332
  • Hart T. B., Nevitt A., Whitehead A. A new statistical approach to the prognostic significance of plasma concentrations. Lancet 1984; 2(8413)1222–1223
  • Scherrmann J. M., Houze P., Bismuth C., Bourdon R. Prognostic value of plasma and urine paraquat concentrations. Hum Toxicol 1987; 6(1)91–93
  • Scherrmann J. M. Analytical procedures and predictive value of late plasma and urine paraquat concentrations. Paraquat Poisoning: Mechanisms‐Prevention‐Treatment, C. Bismuth, A. H. Hall. Marcel Dekker, Inc., New York 1995; 285–296
  • Braithwaite R. A. Emergency analysis of paraquat in biological fluids. Hum Toxicol 1987; 6(1)83–86
  • Addo E., Poon‐King T. Leukocyte suppression in treatment of 72 patients with paraquat poisoning. Lancet 1986; 1(8490)1117–1120
  • Perriens J. H., Benimadho S., Kiauw I. L., Wisse J., Chee H. High dose cyclophosphamide and dexamethasone in paraquat poisoning: a prospective study. Hum Exp Toxicol 1992; 11(2)129–134
  • Naito H., Yamashita M. Epidemiology of paraquat in Japan and a new safe formulation of paraquat. Hum Toxicol 1987; 6(1)87–88
  • Garnier R. Paraquat poisoning by inhalation or skin absorption. Paraquat Poisoning: Mechanisms‐Prevention‐Treatment, C. Bismuth, A. H. Hall. Marcel Dekker, Inc., New York 1995; 211–234
  • Sanchez‐Sellero I., Lopez‐Rivadulla M., Cruz A., Bermejo A., Fernandez P. A sequential spectrophotometric method for the determination of paraquat and diquat in plasma. Anal Lett 1993; 26(9)1891–1904
  • Lin J. L., Wei M. C., Liu Y. C. Pulse therapy with cyclophosphamide and methylprednisolone in patients with moderate to severe paraquat poisoning: a preliminary report. Thorax 1996; 51(7)661–663
  • Lin J. L., Leu M. L., Liu Y. C., Chen G. H. A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat poisoned patients. Am J Respir Crit Care Med 1999; 159(2)357–360
  • Lin J. L., Liu L., Leu M. L. Recovery of respiratory function in survivors with paraquat intoxication. Arch Environ Health 1995; 50(6)432–439
  • Chen G. H., Lin J. L., Huang Y. K. Combined methylprednisolone and dexamethasone therapy for paraquat poisoning. Crit Care Med 2002; 30(11)2584–2587
  • Sato S. Human paraquat toxicology: prognostic factors. Paraquat Poisoning: Mechanisms–Prevention–Treatment, C. Bismuth, A. H. Hall. Marcel Dekker, Inc., New York 1995; 267–274
  • Smith J. G. Paraquat poisoning by skin absorption: a review. Hum Toxicol 1988; 7(1)15–19
  • Ernouf D., Boussa N., Legras A., Dutertre‐Catella H. Acute paraquat poisoning: increased toxicity in one case with high alcohol intake. Hum Exp Toxicol 1998; 17(3)182–184
  • Brand R. M., Charron A., Dutton L., Hannah T. L., Hamel F. G., Donahue T. L. (2002) A single episode of alcohol consumption can increase paraquat absorption through skin. Substance Abuse and Detection, North American Congress of Clinical Toxicology Annual Meeting, California, Sept, 24–292002. J Toxicol Clin Toxicol, 40(5): 648–649
  • Yoshida T., Tanaka M., Sotomatsu A., Okamoto K. Effect of methylprednisolone‐pulse therapy on superoxide production of neutrophils. Neurol Res 1999; 21(5)509–512
  • Luce J. M., Montgomery A. B., Marks J. D., Turner J., Metz C. A., Murray J. F. Ineffectiveness of high‐dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988; 138(1)62–68
  • Meduri G. U., Belenchia J. M., Estes R. J., Wunderink R. G., Torky M. E., Leeper K. V., Jr. Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 1991; 100(4)943–952

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.